RxDoctor Payments Data

Ajay Varma

Interventional Pain Medicine · Holmdel, NJNPI 1841482106

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $6,655 of the $9,130 with a category attached, or 72.9%. It is spread thinly across 26 manufacturers, the largest accounting for just 19.8%. Reporting peaked in 2019 at $2,687 and has fallen 78.5% since, to $579 in 2025.

$9,130in general payments, 2019–2025

Across 214 payments — averaging $42.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Vertiflex, Inc.$2K
  • Medtronic$2K
  • Abbott$1K
  • Nevro Corp.$996
  • Boston Scientific$987
  • Si-bone, Inc.$463
  • plus $2K from 20 others

What the payments were for

  • Travel & lodging$2,47527%
  • Food & beverage$6,65573%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,130 in reported general payments places this provider in the 75th percentile of 82 interventional pain medicine providers in New Jersey.

See all interventional pain medicine providers in New Jersey

Medicare billing

Part B allowed, 2024
$188,143
Medicare patients
209
Services billed
3,270

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OxycontinOxycodone Hcl34$26,284
Gabapentin246$4,102
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen143$3,744
Morphine Sulfate ErMorphine Sulfate126$3,141
Oxycodone Hcl131$1,704
Fentanyl13$1,624
Morphine Sulfate60$1,375
Pregabalin102$1,067
Lidocaine13$818
Duloxetine Hcl48$735
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen51$706
Celecoxib35$463
Diclofenac Sodium16$457
Meloxicam119$449
Acetaminophen-CodeineAcetaminophen With Codeine37$373

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Holmdel

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →